Download PDF
Semin Thromb Hemost
DOI: 10.1055/s-0044-1781450
Review Article

Variable Performance of D-dimer Testing by Hemostasis Laboratories: The Australasian/Asia-Pacific Experience

Emmanuel J. Favaloro 
1   Department of Haematology, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, NSW, Australia
2   Faculty of Science and Health, Charles Sturt University, Wagga Wagga, NSW, Australia
3   School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Westmead Hospital, Westmead, New South Wales, Australia
,
Sandya Arunachalam
4   RCPAQAP Haematology, St Leonards, NSW, Australia
,
Elysse Dean
4   RCPAQAP Haematology, St Leonards, NSW, Australia
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

D-dimers represent the breakdown products of fibrin. Thus, elevated plasma D-dimers will arise following a thrombotic event, such as a deep vein thrombosis or a pulmonary embolism, and therefore, a nonelevated D-dimer is used to effectively exclude such events. D-dimers are also elevated in a range of other conditions, for example, during disseminated intravascular coagulation. D-dimer levels may also be associated with prognostic value. For example, highly raised D-dimer levels can be associated with worsening clinical features in coronavirus disease 2019. Thus, D-dimer testing represents a commonly requested hemostasis test, often performed in 24/7 laboratories. Unfortunately, D-dimer testing is neither standardized nor harmonized across manufacturers or laboratories. Indeed, considering reporting units and the magnitude of units, up to 28 different combinations may be reported by laboratories. We provide updated findings for D-dimer testing in our geographic region, using recent data from the Royal College of Pathologists of Australasia Quality Assurance Programs, an international external quality assessment program, currently with over 450 participants in the D-dimer module. Data show a wide variety of assays in use and variable outcomes in reported numerical values when assessing proficiency samples. D-dimer testing mostly comprised reagents from three main manufacturing suppliers, with a small number of users of reagents from other manufacturers. Reported results showed important differences in numerical values for the same homogeneous tested samples when normalized to a single reporting unit (e.g., mg/L). Nevertheless, despite using different test reagents and reporting, most participants uniformly identified D-dimer values as below or above a “detection” cut-off for samples that were constructed to be below or above most cut-off values. As expected, mixed findings were reported for samples containing levels around expected cut-off values. We hope that our findings, reflecting on the heterogeneity of test reagents and test data, help improve diagnostic testing for D-dimer testing and facilitate harmonization and standardization, in the future.

Keywords

D-dimer - thrombosis exclusion - external quality assessment - proficiency testing - assay variability

Supplementary Material



Publication History

Article published online:
01 March 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Thachil J, Favaloro EJ, Lippi G. D-dimers-“normal” levels versus elevated levels due to a range of conditions, including “D-dimeritis,” inflammation, thromboembolism, disseminated intravascular coagulation, and COVID-19. Semin Thromb Hemost 2022; 48 (06) 672-679
    Google Scholar
  • 2 Lippi G, Favaloro EJ. D-dimer is associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis. Thromb Haemost 2020; 120 (05) 876-878
    Google Scholar
  • 3 Lippi G, Favaloro EJ. D-dimer measurement in COVID-19: silver bullet or clinical distraction?. Thromb Res 2020; 196: 635-637
    Google Scholar
  • 4 Favaloro EJ, Pasalic L, Lippi G. Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT). Clin Chem Lab Med 2021; 60 (01) 7-17
    Google Scholar
  • 5 Favaloro EJ, Clifford J, Leitinger E. et al. Assessment of immunological anti-platelet factor 4 antibodies for vaccine-induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: a multicenter study comprising 1284 patients. J Thromb Haemost 2022; 20 (12) 2896-2908
    Google Scholar
  • 6 Longstaff C, Adcock D, Olson JD. et al. Harmonisation of D-dimer—a call for action. Thromb Res 2016; 137: 219-220
    Google Scholar
  • 7 Lippi G, Tripodi A, Simundic AM, Favaloro EJ. International survey on D-dimer test reporting: a call for standardization. Semin Thromb Hemost 2015; 41 (03) 287-293
    Google Scholar
  • 8 Favaloro EJ, Dean E. Variability in D-dimer reporting revisited. Pathology 2021; 53 (04) 538-540
    Google Scholar
  • 9 Favaloro EJ, Thachil J. Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation. Clin Chem Lab Med 2020; 58 (08) 1191-1199
    Google Scholar
  • 10 CLSI. Quantitative D-dimer for the Exclusion of Venous Thromboembolic Disease; Approved Guideline. CLSI document H59-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2011
    Google Scholar
  • 11 Selby S, Favaloro EJ, Meijer P. D-dimer diagnostics: can i use any D-dimer assay? Bridging the knowledge-to-action gap. Res Pract Thromb Haemost 2024; DOI: 10.1016/j.rpth.2024.102335.
    Google Scholar
  • 12 Arisz RA, Meijer P, Péquériaux NCV. et al. Impact of COVID-19 pandemic on the quality of test output in haemostasis laboratories. Int J Lab Hematol 2022; 44 (02) 407-413
    Google Scholar
  • 13 Favaloro EJ, Lay M, Mohammed S, Vong R, Pasalic L. Pathology utilisation during COVID-19 outbreaks beyond viral testing: routine coagulation and D-dimer testing. Pathology 2023; 55 (01) 155-159
    Google Scholar
  • 14 Smock KJ, Moser KA. What have we learned from coagulation laboratory participation in external quality programs?. Int J Lab Hematol 2019; 41 (Suppl. 01) 49-55
    Google Scholar
  • 15 Aggett H, Dabula P, Mayne ES, Louw S. A pilot study to introduce a local external quality assurance scheme for D-dimers in the National Health Laboratory Service, in South Africa. Int J Lab Hematol 2019; 41 (02) 298-303
    Google Scholar
  • 16 de Maat MP, Meijer P, Nieuwenhuizen W, Haverkate F, Kluft C. Performance of semiquantitative and quantitative D-dimer assays in the ECAT external quality assessment program. Semin Thromb Hemost 2000; 26 (06) 625-630
    Google Scholar
  • 17 Matsuno K, Yasushi T. Quality control and quality assessment of coagulation tests in Japan. Southeast Asian J Trop Med Public Health 2002; 33 (Suppl. 02) 99-103
    Google Scholar
  • 18 Cunningham MT, Olson JD. Proficiency testing finds too-high cutoffs. CAP Today 2005; 19 (05) 54 , 58
    Google Scholar
  • 19 Spannagl M, Haverkate F, Reinauer H, Meijer P. The performance of quantitative D-dimer assays in laboratory routine. Blood Coagul Fibrinolysis 2005; 16 (06) 439-443
    Google Scholar
  • 20 Tripodi A, Chantarangkul V. Performance of quantitative D-dimer methods: results of the Italian external quality assessment scheme. J Thromb Haemost 2007; 5 (01) 184-185
    Google Scholar
  • 21 Favaloro EJ, Bonar R. Emerging technologies and quality assurance in hemostasis: a review of findings from the Royal College of Pathologists of Australasia Quality Assurance Program. Semin Thromb Hemost 2007; 33 (03) 235-242
    Google Scholar
  • 22 Jennings I, Kitchen DP, Woods TA, Kitchen S, Walker ID. Emerging technologies and quality assurance: the United Kingdom National External Quality Assessment Scheme perspective. Semin Thromb Hemost 2007; 33 (03) 243-249
    Google Scholar
  • 23 Favaloro EJ. Standardization, regulation, quality assurance and emerging technologies in hemostasis: issues, controversies, benefits, and limitations. Semin Thromb Hemost 2007; 33 (03) 290-297
    Google Scholar
  • 24 Crowther MA, Bates SM, Keeney M, Raby A, Flynn G. Human-derived D-dimer for external quality assessment: results of four surveys in Ontario. Am J Clin Pathol 2008; 130 (05) 805-810
    Google Scholar
  • 25 Olson JD, Cunningham MT, Higgins RA, Eby CS, Brandt JT. D-dimer: simple test, tough problems. Arch Pathol Lab Med 2013; 137 (08) 1030-1038
    Google Scholar
  • 26 Bevan S, Longstaff C. Is it possible to make a common reference standard for D-dimer measurements? Communication from the ISTH SSC Subcommittee on Fibrinolysis. J Thromb Haemost 2022; 20 (02) 498-507
    Google Scholar
  • 27 Meijer P, Haverkate F, Kluft C, de Moerloose P, Verbruggen B, Spannagl M. A model for the harmonisation of test results of different quantitative D-dimer methods. Thromb Haemost 2006; 95 (03) 567-572
    Google Scholar
  • 28 García de Guadiana-Romualdo L, Morell-García D, Favaloro EJ. et al. Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: results from a Spanish multicenter registry (BIOCOVID-Spain study). J Thromb Thrombolysis 2022; 53 (01) 103-112
    Google Scholar
  • 29 Thachil J, Longstaff C, Favaloro EJ, Lippi G, Urano T, Kim PY. SSC Subcommittee on Fibrinolysis of the International Society on Thrombosis and Haemostasis. The need for accurate D-dimer reporting in COVID-19: communication from the ISTH SSC on fibrinolysis. J Thromb Haemost 2020; 18 (09) 2408-2411
    Google Scholar